ABSI
Absci Corp
Key Financials
Operating Income
$-120317000
↓ 10.5%
Revenue
$4.5M
↓ 20.7%
Total Assets
$216.3M
↑ 1.3%
EPS (Diluted)
$-0.84
↑ 10.6%
Shareholders' Equity
$189.4M
↑ 5.8%
Total Liabilities
$26.8M
↓ 22.1%
Net Income
$-115183000
↓ 11.7%
Long-term Debt
$4.0M
↓ 49.6%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | ABSI |
| Company Name | Absci Corp |
| CIK | 1672688 |
| SIC Code | 8731 |
| SIC Description | Services-Commercial Physical & Biological Research |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| Phone | (360) 949-1041 |